What we're reading, March 30, 2016: the Supreme Court asks for more information in birth control case; Americans display lack of knowledge about Zika virus; and China provides an opportunity for drugs that fail to make it to market elsewhere.
With only 8 sitting members on the Supreme Court, the judges appear deadlocked on an important case on contraception access. Kaiser Health News reported that the court has asked lawyers involved in the case to provide more information on how women working for religious employers may access birth control. The judges had seemed evenly divided after arguments last week, and the court is also asking the lawyers to provide a possible compromise in the case.
Although Americans recognize that the Zika virus is spreading and could reach the continental US, they are unaware of the basic facts of the virus. While a large majority of people realize the virus is spread by mosquitoes, one-third also believe Zika can be spread by coughing or sneezing, according to USA Today. In addition, nearly one-fourth of adults in households where someone is pregnant or considering becoming pregnant didn’t know about the link between Zika and microcephaly.
China is providing a second life for some drugs that don’t make it to market elsewhere in the world. Companies licensing drugs to Chinese startups after a treatment fails to outperform other drugs is becoming a new trend, reported The Wall Street Journal. However, it isn’t unusual or unlawful for companies to get a drug approved in one jurisdiction but not another, and in China companies don’t have to prove a drug’s superiority over existing treatments.
Disparities in Telehealth Access Undermine Adoption Among Patients With Schizophrenia
January 16th 2025The COVID-19 pandemic accelerated the widespread adoption of telemental health care, and new research indicates significant racial and ethnic disparities in access to this technology among Medicaid beneficiaries with schizophrenia.
Read More
Study Suggests Postdischarge Care Needs Targeted, Multifaceted Approaches
January 15th 2025The findings challenge the effectiveness of these widely used transitional care interventions and suggest a need for more targeted, multifaceted approaches to address the needs of higher-risk patients.
Read More
Frameworks for Advancing Health Equity: Pharmacy Support for Non-Hodgkin Lymphoma
December 19th 2024Rachael Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with insurance companies and providers to support treatment access for patients with non-Hodgkin lymphoma.
Listen